March 19 (Reuters) - The U.S. Food and Drug Administration approved GSK's drug for severe itching caused by a type of liver disease, the company said on Thursday. The drug, branded Lynavoy, was ...

Peking University, October 30, 2024: Addressing the challenge of cholestatic itch, the scientific community has been pursuing innovative solutions. Recently, researchers from Peking University, led by ...

GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Saturday, March 21, 2026, 11:00 Hrs [IST] GSK plc announ ...

Cirrhosis can cause scar tissue to gradually replace healthy liver cells. In time, this can affect liver function and lead to hair, skin, and nail symptoms such as rashes and discoloration. Cirrhosis ...

For the best experience, please enable JavaScript in your browser settings. UK: A tormented toddler's rare liver disease causes him to itch so much he deliberately ...

Alfasigma’s buzzer-beater bet on GSK’s rare liver disease prospect has paid off. After inking a deal worth up to $690 million to take on worldwide rights to the med last week, the FDA has doled out an ...

PHOENIX — Seladelpar, a first-in-class, selective peroxisome proliferator-activated receptor delta agonist, shows significant improvement across key pruritus outcomes in patients with primary biliary ...

Please provide your email address to receive an email when new articles are posted on . Seladelpar effectively reduced pruritus in patients with primary biliary cholangitis following 6 months of ...

A small amount of fat in your liver is healthy, but when fat makes up more than 5% of your liver's weight, it can cause problems. At this point, doctors call it steatotic liver disease, although you ...